Annual Shareholders Equity
$41.10 M
-$41.57 M-50.28%
31 December 2023
Summary:
Assembly Biosciences annual stockholders equity is currently $41.10 million, with the most recent change of -$41.57 million (-50.28%) on 31 December 2023. During the last 3 years, it has fallen by -$199.48 million (-82.92%). ASMB annual shareholders equity is now -84.96% below its all-time high of $273.22 million, reached on 31 December 2019.ASMB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$26.00 M
-$8.68 M-25.02%
30 September 2024
Summary:
Assembly Biosciences quarterly stockholders equity is currently $26.00 million, with the most recent change of -$8.68 million (-25.02%) on 30 September 2024. Over the past year, it has dropped by -$15.71 million (-37.66%). ASMB quarterly shareholders equity is now -90.48% below its all-time high of $273.22 million, reached on 31 December 2019.ASMB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASMB Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.3% | -37.7% |
| 3 y3 years | -82.9% | -88.4% |
| 5 y5 years | -80.5% | -83.4% |
ASMB Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -82.9% | at low | -88.4% | at low |
| 5 y | 5 years | -85.0% | at low | -90.5% | at low |
| alltime | all time | -85.0% | +407.6% | -90.5% | +253.3% |
Assembly Biosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $26.00 M(-25.0%) |
| June 2024 | - | $34.68 M(+6.4%) |
| Mar 2024 | - | $32.60 M(-20.7%) |
| Dec 2023 | $41.10 M(-50.3%) | $41.10 M(-1.5%) |
| Sept 2023 | - | $41.71 M(-24.1%) |
| June 2023 | - | $54.95 M(-21.9%) |
| Mar 2023 | - | $70.33 M(-14.9%) |
| Dec 2022 | $82.66 M(-51.1%) | $82.66 M(-19.3%) |
| Sept 2022 | - | $102.40 M(-17.4%) |
| June 2022 | - | $123.98 M(-15.5%) |
| Mar 2022 | - | $146.79 M(-13.1%) |
| Dec 2021 | $168.93 M(-29.8%) | $168.93 M(-24.8%) |
| Sept 2021 | - | $224.65 M(-3.1%) |
| June 2021 | - | $231.79 M(-6.2%) |
| Mar 2021 | - | $247.24 M(+2.8%) |
| Dec 2020 | $240.58 M(-11.9%) | $240.58 M(-11.1%) |
| Sept 2020 | - | $270.55 M(+1.3%) |
| June 2020 | - | $267.12 M(+6.1%) |
| Mar 2020 | - | $251.77 M(-7.9%) |
| Dec 2019 | $273.22 M(+29.7%) | $273.22 M(+74.6%) |
| Sept 2019 | - | $156.49 M(-10.4%) |
| June 2019 | - | $174.71 M(-8.2%) |
| Mar 2019 | - | $190.40 M(-9.6%) |
| Dec 2018 | $210.65 M(+86.2%) | $210.65 M(-8.2%) |
| Sept 2018 | - | $229.43 M(+157.5%) |
| June 2018 | - | $89.10 M(-13.0%) |
| Mar 2018 | - | $102.38 M(-9.5%) |
| Dec 2017 | $113.12 M | $113.12 M(+140.0%) |
| Sept 2017 | - | $47.13 M(-16.6%) |
| June 2017 | - | $56.53 M(-16.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $67.89 M(-15.0%) |
| Dec 2016 | $79.88 M(-32.7%) | $79.88 M(-11.3%) |
| Sept 2016 | - | $90.04 M(-10.5%) |
| June 2016 | - | $100.56 M(-8.0%) |
| Mar 2016 | - | $109.28 M(-8.0%) |
| Dec 2015 | $118.74 M(+102.7%) | $118.74 M(-5.3%) |
| Sept 2015 | - | $125.40 M(-4.2%) |
| June 2015 | - | $130.87 M(+5.0%) |
| Mar 2015 | - | $124.62 M(+112.8%) |
| Dec 2014 | $58.57 M(+139.1%) | $58.57 M(+24.1%) |
| Sept 2014 | - | $47.20 M(+132.7%) |
| June 2014 | - | $20.29 M(-9.6%) |
| Mar 2014 | - | $22.44 M(-8.4%) |
| Dec 2013 | $24.49 M(+37.5%) | $24.49 M(-18.5%) |
| Sept 2013 | - | $30.05 M(-3.4%) |
| June 2013 | - | $31.09 M(-11.5%) |
| Mar 2013 | - | $35.13 M(+97.2%) |
| Dec 2012 | $17.81 M(-48.4%) | $17.81 M(-15.2%) |
| Sept 2012 | - | $21.00 M(-18.0%) |
| June 2012 | - | $25.62 M(-7.0%) |
| Mar 2012 | - | $27.54 M(-20.3%) |
| Dec 2011 | $34.53 M(+197.0%) | $34.53 M(-33.9%) |
| Sept 2011 | - | $52.20 M(+453.4%) |
| June 2011 | - | $9.43 M(-24.7%) |
| Mar 2011 | - | $12.53 M(+7.8%) |
| Dec 2010 | $11.63 M(-187.0%) | $11.63 M(-168.6%) |
| Sept 2010 | - | -$16.96 M(+12.5%) |
| June 2010 | - | -$15.07 M(+11.6%) |
| Mar 2010 | - | -$13.50 M(+1.0%) |
| Dec 2009 | -$13.36 M(+41.3%) | -$13.36 M |
| Dec 2008 | -$9.46 M | - |
FAQ
- What is Assembly Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Assembly Biosciences?
- What is Assembly Biosciences annual shareholders equity year-on-year change?
- What is Assembly Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Assembly Biosciences?
- What is Assembly Biosciences quarterly shareholders equity year-on-year change?
What is Assembly Biosciences annual stockholders equity?
The current annual shareholders equity of ASMB is $41.10 M
What is the all time high annual shareholders equity for Assembly Biosciences?
Assembly Biosciences all-time high annual stockholders equity is $273.22 M
What is Assembly Biosciences annual shareholders equity year-on-year change?
Over the past year, ASMB annual stockholders equity has changed by -$41.57 M (-50.28%)
What is Assembly Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of ASMB is $26.00 M
What is the all time high quarterly shareholders equity for Assembly Biosciences?
Assembly Biosciences all-time high quarterly stockholders equity is $273.22 M
What is Assembly Biosciences quarterly shareholders equity year-on-year change?
Over the past year, ASMB quarterly stockholders equity has changed by -$15.71 M (-37.66%)